Type 1 fimbriae minor subunit FimG (FimG)

Type 1 fimbriae minor subunit FimG is a structural protein and adaptor component of the Type 1 fimbriae, which are hair-like appendages used by Gram-negative bacteria like uropathogenic Escherichia coli (UPEC) to colonize host tissues [2.3.1, 2.4.1]. Located within the tip fibrillum, FimG serves as a critical link between the mannose-binding adhesin FimH and the major fimbrial rod, ensuring the proper assembly and stability of the adhesive organelle [2.4.3, 3.1.2]. It is involved in regulating the length of the fimbriae and is essential for the functional display of FimH, which mediates attachment to mannosylated receptors on the urothelium [2.3.1, 3.4.2]. Due to its central role in bacterial adhesion, invasion, and biofilm formation, FimG is considered a significant target for anti-virulence therapies [2.5.5, 3.2.1]. Experimental strategies include the use of pilicides to disrupt the chaperone-usher assembly pathway and the development of subunit vaccines to induce protective immunity against urinary tract infections [3.2.3, 3.5.2]. By targeting the assembly or function of the fimbrial tip complex, these approaches aim to provide antibiotic-sparing treatments for recurrent infections and reduce the burden of antimicrobial resistance [2.1.2, 3.3.1].

Other names

Protein FimGMinor fimbrial subunit FimGType 1 pilin FimGFimbrial protein FimG

Inhibition of fimbrial assembly by targeting the chaperone-usher pathway or competitive inhibition of host cell attachment by targeting the fimbrial tip complex.